Cargando…
Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review
The altered cellular gene expression profile is being hypothesized as the possible molecular basis navigating the onset or progress of various morbidities. This hypothesis has been evaluated here in respect of Cr(6+) induced toxicity. Several studies using gene microarray show selective and strategi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069729/ https://www.ncbi.nlm.nih.gov/pubmed/24820829 |
_version_ | 1782322603541659648 |
---|---|
author | Nigam, Akanksha Priya, Shivam Bajpai, Preeti Kumar, Sushil |
author_facet | Nigam, Akanksha Priya, Shivam Bajpai, Preeti Kumar, Sushil |
author_sort | Nigam, Akanksha |
collection | PubMed |
description | The altered cellular gene expression profile is being hypothesized as the possible molecular basis navigating the onset or progress of various morbidities. This hypothesis has been evaluated here in respect of Cr(6+) induced toxicity. Several studies using gene microarray show selective and strategic dysregulations of cellular genes and pathways induced by Cr(6+). Relevant literature has been reviewed to unravel these changes in different test systems after exposure to Cr(6+) and also to elucidate association if any, of the altered cytogenomics with Cr(6+) induced toxicity or carcinogenicity. The aim was to verify the hypothesis for critical role of altered cytogenomics in onset of Cr(6+) induced biological / clinical effects by identifying genes modulated commonly by the toxicant irrespective of test system or test concentrations / doses, and by scrutinizing their importance in regulation of the flow of mechanistically linked events crucial for resultant morbidities. Their probability as biomarkers to monitor the toxicant induced biological changes is speculative. The modulated genes have been found to cluster under the pathways that manage onset of oxidative stress, DNA damage, apoptosis, cell-cycle regulation, cytoskeleton, morphological changes, energy metabolism, biosynthesis, oncogenes, bioenergetics, and immune system critical for toxicity. In these studies, the identity of genes has been found to differ remarkably; albeit the trend of pathways’ dysregulation has been found to remain similar. We conclude that the intensity of dysregulation of genes or pathways involved in mechanistic events forms a sub-threshold or threshold level depending upon the dose and type (including speciation) of the toxicant, duration of exposure, type of target cells, and niche microenvironment of cells, and the intensity of sub-threshold or threshold level of the altered cytogenomics paves way in toxicant exposed cells eventually either to opt for reversal to differentiation and growth, or to result in toxicity like dedifferentiation and apoptosis, respectively. |
format | Online Article Text |
id | pubmed-4069729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40697292014-07-01 Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review Nigam, Akanksha Priya, Shivam Bajpai, Preeti Kumar, Sushil Indian J Med Res Review Article The altered cellular gene expression profile is being hypothesized as the possible molecular basis navigating the onset or progress of various morbidities. This hypothesis has been evaluated here in respect of Cr(6+) induced toxicity. Several studies using gene microarray show selective and strategic dysregulations of cellular genes and pathways induced by Cr(6+). Relevant literature has been reviewed to unravel these changes in different test systems after exposure to Cr(6+) and also to elucidate association if any, of the altered cytogenomics with Cr(6+) induced toxicity or carcinogenicity. The aim was to verify the hypothesis for critical role of altered cytogenomics in onset of Cr(6+) induced biological / clinical effects by identifying genes modulated commonly by the toxicant irrespective of test system or test concentrations / doses, and by scrutinizing their importance in regulation of the flow of mechanistically linked events crucial for resultant morbidities. Their probability as biomarkers to monitor the toxicant induced biological changes is speculative. The modulated genes have been found to cluster under the pathways that manage onset of oxidative stress, DNA damage, apoptosis, cell-cycle regulation, cytoskeleton, morphological changes, energy metabolism, biosynthesis, oncogenes, bioenergetics, and immune system critical for toxicity. In these studies, the identity of genes has been found to differ remarkably; albeit the trend of pathways’ dysregulation has been found to remain similar. We conclude that the intensity of dysregulation of genes or pathways involved in mechanistic events forms a sub-threshold or threshold level depending upon the dose and type (including speciation) of the toxicant, duration of exposure, type of target cells, and niche microenvironment of cells, and the intensity of sub-threshold or threshold level of the altered cytogenomics paves way in toxicant exposed cells eventually either to opt for reversal to differentiation and growth, or to result in toxicity like dedifferentiation and apoptosis, respectively. Medknow Publications & Media Pvt Ltd 2014-03 /pmc/articles/PMC4069729/ /pubmed/24820829 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Nigam, Akanksha Priya, Shivam Bajpai, Preeti Kumar, Sushil Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title | Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title_full | Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title_fullStr | Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title_full_unstemmed | Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title_short | Cytogenomics of hexavalent chromium (Cr(6+)) exposed cells: A comprehensive review |
title_sort | cytogenomics of hexavalent chromium (cr(6+)) exposed cells: a comprehensive review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069729/ https://www.ncbi.nlm.nih.gov/pubmed/24820829 |
work_keys_str_mv | AT nigamakanksha cytogenomicsofhexavalentchromiumcr6exposedcellsacomprehensivereview AT priyashivam cytogenomicsofhexavalentchromiumcr6exposedcellsacomprehensivereview AT bajpaipreeti cytogenomicsofhexavalentchromiumcr6exposedcellsacomprehensivereview AT kumarsushil cytogenomicsofhexavalentchromiumcr6exposedcellsacomprehensivereview |